249 related articles for article (PubMed ID: 34726838)
1. Next-generation sequencing in the evaluation of biliary strictures in patients with primary sclerosing cholangitis.
Scheid JF; Rosenbaum MW; Przybyszewski EM; Krishnan K; Forcione DG; Iafrate AJ; Staller KD; Misdraji J; Lennerz JK; Pitman MB; Pratt DS
Cancer Cytopathol; 2022 Mar; 130(3):215-230. PubMed ID: 34726838
[TBL] [Abstract][Full Text] [Related]
2. NGS of brush cytology samples improves the detection of high-grade dysplasia and cholangiocarcinoma in patients with primary sclerosing cholangitis: A retrospective and prospective study.
Boyd S; Mustamäki T; Sjöblom N; Nordin A; Tenca A; Jokelainen K; Rantapero T; Liuksiala T; Lahtinen L; Kuopio T; Kytölä S; Mäkisalo H; Färkkilä M; Arola J
Hepatol Commun; 2024 Apr; 8(4):. PubMed ID: 38551383
[TBL] [Abstract][Full Text] [Related]
3. Next-generation sequencing mutation analysis on biliary brush cytology for differentiation of benign and malignant strictures in primary sclerosing cholangitis.
Kamp EJCA; Dinjens WNM; van Velthuysen MF; de Jonge PJF; Bruno MJ; Peppelenbosch MP; de Vries AC
Gastrointest Endosc; 2023 Mar; 97(3):456-465.e6. PubMed ID: 36252869
[TBL] [Abstract][Full Text] [Related]
4. Polysomy and p16 deletion by fluorescence in situ hybridization in the diagnosis of indeterminate biliary strictures.
Gonda TA; Glick MP; Sethi A; Poneros JM; Palmas W; Iqbal S; Gonzalez S; Nandula SV; Emond JC; Brown RS; Murty VV; Stevens PD
Gastrointest Endosc; 2012 Jan; 75(1):74-9. PubMed ID: 22100297
[TBL] [Abstract][Full Text] [Related]
5. Impact of trimodality sampling on detection of malignant biliary strictures compared with patients with primary sclerosing cholangitis.
Baroud S; Sahakian AJ; Sawas T; Storm AC; Martin JA; Abu Dayyeh BK; Topazian MD; Levy MJ; Roberts LR; Gores GJ; Petersen BT; Chandrasekhara V
Gastrointest Endosc; 2022 May; 95(5):884-892. PubMed ID: 34871554
[TBL] [Abstract][Full Text] [Related]
6. Evaluating the Significance of Pancreatobiliary Fluorescence In Situ Hybridization Polysomy on Prognosis in De Novo Cholangiocarcinoma.
Ji H; Barr Fritcher EG; Yin J; Bainter TM; Zemla TJ; Gores GJ; Halling KC; Kipp BR; Roberts LR
Clin Transl Gastroenterol; 2022 Oct; 13(10):e00523. PubMed ID: 36000989
[TBL] [Abstract][Full Text] [Related]
7. Primary sclerosing cholangitis and cholangiocarcinoma.
Lazaridis KN; Gores GJ
Semin Liver Dis; 2006 Feb; 26(1):42-51. PubMed ID: 16496232
[TBL] [Abstract][Full Text] [Related]
8. Clinical implications of serial versus isolated biliary fluorescence in situ hybridization (FISH) polysomy in primary sclerosing cholangitis.
Quinn KP; Tabibian JH; Lindor KD
Scand J Gastroenterol; 2017 Apr; 52(4):377-381. PubMed ID: 27908204
[TBL] [Abstract][Full Text] [Related]
9. Biliary dysplasia in primary sclerosing cholangitis harbors cytogenetic abnormalities similar to cholangiocarcinoma.
Kerr SE; Barr Fritcher EG; Campion MB; Voss JS; Kipp BR; Halling KC; Lewis JT
Hum Pathol; 2014 Sep; 45(9):1797-804. PubMed ID: 25027853
[TBL] [Abstract][Full Text] [Related]
10. Cost utility of ERCP-based modalities for the diagnosis of cholangiocarcinoma in primary sclerosing cholangitis.
Njei B; McCarty TR; Varadarajulu S; Navaneethan U
Gastrointest Endosc; 2017 Apr; 85(4):773-781.e10. PubMed ID: 27590963
[TBL] [Abstract][Full Text] [Related]
11. Screening and diagnosis of cholangiocarcinoma in patients with primary sclerosing cholangitis.
Jesudian AB; Jacobson IM
Rev Gastroenterol Disord; 2009; 9(2):E41-7. PubMed ID: 19668124
[TBL] [Abstract][Full Text] [Related]
12. Recall processes for biliary cytology in primary sclerosing cholangitis.
Eaton JE; Gossard AA; Talwalkar JA
Curr Opin Gastroenterol; 2014 May; 30(3):287-94. PubMed ID: 24686433
[TBL] [Abstract][Full Text] [Related]
13. Primary Sclerosing Cholangitis-Associated Cholangiocarcinoma Demonstrates High Intertumor and Intratumor Heterogeneity.
Kamp EJCA; Peppelenbosch MP; Doukas M; Verheij J; Ponsioen CY; van Marion R; Bruno MJ; Groot Koerkamp B; Dinjens WNM; de Vries AC
Clin Transl Gastroenterol; 2021 Oct; 12(10):e00410. PubMed ID: 34608877
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic performance of a stepwise cytological algorithm for biliary malignancy in primary sclerosing cholangitis.
von Seth E; Ouchterlony H; Dobra K; Hjerpe A; Arnelo U; Haas S; Bergquist A
Liver Int; 2019 Feb; 39(2):382-388. PubMed ID: 30507030
[TBL] [Abstract][Full Text] [Related]
15. Role of Ancillary Techniques in Biliary Cytopathology Specimens.
Layfield L
Acta Cytol; 2020; 64(1-2):175-181. PubMed ID: 31121596
[TBL] [Abstract][Full Text] [Related]
16. Surveillance of primary sclerosing cholangitis with ERC and brush cytology: risk factors for cholangiocarcinoma.
Boyd S; Mustonen H; Tenca A; Jokelainen K; Arola J; Färkkilä MA
Scand J Gastroenterol; 2017 Feb; 52(2):242-249. PubMed ID: 27806633
[TBL] [Abstract][Full Text] [Related]
17. Cholangiocarcinoma in primary sclerosing cholangitis.
Abbas G; Lindor KD
J Gastrointest Cancer; 2009; 40(1-2):19-25. PubMed ID: 19705300
[TBL] [Abstract][Full Text] [Related]
18. The Cytomorphologic and Molecular Assessment of Bile Duct Brushing Specimens.
Hilburn CF; Pitman MB
Surg Pathol Clin; 2022 Sep; 15(3):469-478. PubMed ID: 36049829
[TBL] [Abstract][Full Text] [Related]
19. Primary sclerosing cholangitis patients with serial polysomy fluorescence in situ hybridization results are at increased risk of cholangiocarcinoma.
Barr Fritcher EG; Kipp BR; Voss JS; Clayton AC; Lindor KD; Halling KC; Gores GJ
Am J Gastroenterol; 2011 Nov; 106(11):2023-8. PubMed ID: 21844920
[TBL] [Abstract][Full Text] [Related]
20. Fluorescence in situ hybridization compared with conventional cytology for the diagnosis of malignant biliary tract strictures in Asian patients.
Chaiteerakij R; Barr Fritcher EG; Angsuwatcharakon P; Ridtitid W; Chaithongrat S; Leerapun A; Baron TH; Kipp BR; Henry MR; Halling KC; Rerknimitr R; Roberts LR
Gastrointest Endosc; 2016 Jun; 83(6):1228-35. PubMed ID: 26684604
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
